Carnegie Investment Counsel’s iShares Morningstar Mid-Cap ETF IMCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.62M Buy
68,570
+8,239
+14% +$753K 0.13% 147
2026
Q1
$5.03M Sell
60,331
-137
-0.2% -$11.7K 0.1% 175
2025
Q4
$5M Buy
60,468
+4,792
+9% +$396K 0.09% 179
2025
Q3
$4.62M Buy
55,676
+48,741
+703% +$3.98M 0.09% 184
2025
Q2
$552K Buy
+6,935
New +$519K 0.01% 374

Other funds holding IMCB

Carnegie Investment Counsel's IMCB Position: Q2 2026 in Review

Carnegie Investment Counsel increased its iShares Morningstar Mid-Cap ETF (IMCB) stake by 14% in Q2 2026, buying an estimated $753K and bringing the position to 68,570 shares worth $6.62M. The position accounts for 0.13% of the portfolio, ranked #147.

Carnegie Investment Counsel first reported a position in IMCB in Q2 2025 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold IMCB as of Q2 2026.

  • Carnegie Investment Counsel held 68,570 shares of iShares Morningstar Mid-Cap ETF worth $6.62M as of Q2 2026.
  • Carnegie Investment Counsel bought 8,239 iShares Morningstar Mid-Cap ETF shares in Q2 2026, an estimated $753K.
  • iShares Morningstar Mid-Cap ETF made up 0.13% of Carnegie Investment Counsel's portfolio in Q2 2026, its #147 holding.
  • Carnegie Investment Counsel first reported a position in iShares Morningstar Mid-Cap ETF in Q2 2025 and has held it in 5 quarters since.
  • 114 funds tracked by Wall St. Rank held iShares Morningstar Mid-Cap ETF as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.